EPHA2 and glioma: IL-13 receptor alpha 2 (IL13Rα2), human epidermal growth factor receptor 2 (HER2), and Ephrin type A receptor 2 (EphA2) are all glioma-specific antigens that provide targets for CAR-based immunotherapy (76–78).